The primary objective of invasive treatment strategies for multivessel coronary artery disease is complete anatomical revascularization. As objective evidence of ischemia can be provided by a ...

The company reported revenue of $37.2 million in the first quarter, up 39% year-over-year, but said it has faced challenges ...

We randomly assigned 5179 patients with moderate or severe ischemia to an initial invasive strategy (angiography and revascularization when feasible) and medical therapy or to an initial ...

Deciding which patients should undergo coronary revascularization remains a key challenge in the management of coronary artery disease, with individual physicians' practice patterns varying widely ...

New 10-year data from the DANAMI-3-PRIMULTI trial show long-term benefits of complete revascularization for patients with ...

Background: Although practice guidelines recommend coronary revascularization for patients with heart failure, the evidence to support this recommendation is weak. The objective of our study was to ...

Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization. Circulation , 2024; DOI: 10.1161/CIRCULATIONAHA.123.065277 Cite This Page : ...

Perfuze, a medical device company developing catheter technology for interventional stroke care, today announced positive ...

Among the patients with single-vessel disease, the mode of revascularization was typically PCI, which makes intuitive sense and is consistent with guidelines.2 – 4 Most of the variation in the ...

Repeat revascularization performed for recurring disease at a lesion or artery previously treated was associated with an increased risk of all-cause and cardiovascular mortality. In contrast, neither ...

Debate 1: Complete Revascularization - Pedantic Dogma versus Complete Revascularization - Anything Less is Sloppy. Presenter: Akshay Bagai. February 24, 2022. Presentation CTO 2022. CTO Regulatory ...